Sougawa Nagako

Affiliation and department：
Papers (22)：

Nagako Sougawa, Shigeru Miyagawa, Yoshiki Sawa. Large-Scale Differentiation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Stirring-Type Suspension Culture. Methods in molecular biology (Clifton, N.J.). 2021. 2320. 23-27
Nagako Sougawa, Shigeru Miyagawa, Satsuki Fukushima, Junya Yokoyama, Mutsunori Kitahara, Akima Harada, Noriko Mochizuki-Oda, Ryoko Sato-Nishiuchi, Kiyotoshi Sekiguchi, Yoshiki Sawa. Laminin-511 Supplementation Enhances Stem Cell Localization With Suppression in the Decline of Cardiac Function in Acute Infarct Rats. Transplantation. 2019. 103. 5. e119-e127
Daisuke Mori, Shigeru Miyagawa, Ryohei Matsuura, Nagako Sougawa, Satsuki Fukushima, Takayoshi Ueno, Koichi Toda, Toru Kuratani, Koichi Tomita, Norikazu Maeda, et al. Pioglitazone strengthen therapeutic effect of adipose-derived regenerative cells against ischemic cardiomyopathy through enhanced expression of adiponectin and modulation of macrophage phenotype. Cardiovascular diabetology. 2019. 18. 1. 39-39
Emiko Ito, Shigeru Miyagawa, Maki Takeda, Ai Kawamura, Akima Harada, Hiroko Iseoka, Shin Yajima, Nagako Sougawa, Noriko Mochizuki-Oda, Satoshi Yasuda, et al. Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application. Scientific reports. 2019. 9. 1. 1881-1881
Nagako Sougawa, Shigeru Miyagawa, Satsuki Fukushima, Ai Kawamura, Junya Yokoyama, Emiko Ito, Akima Harada, Kaori Okimoto, Noriko Mochizuki-Oda, Atsuhiro Saito, et al. Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy. Scientific reports. 2018. 8. 1. 3726-3726

ｍore...

MISC (7)：

寒川延子, 宮川繁, 原田明希摩, 小田紀子[望月], 佐藤涼子[西内], 関口清俊, 澤芳樹. 急性心筋梗塞に対する人工細胞外基質ラミニン511とONO1301の共投与による有用性の検討. 人工臓器. 2019. 48. 2. S-124
Nagako Sougawa, Shigeru Miyagawa, Satsuki Fukushima, Ai Kawamura, Emiko Ito, Junya Yokoyama, Shigeo Masuda, Atsuhiro Saito, Yoshiki Sawa. A Promising in vitro Treatment to Reduce Tumorigenicity in iPSCBased Cardiomyogenesis Therapy by Antibody-Drug Conjugate Selectively Targeting Undifferentiated iPSCs Contaminating in the Graft. CIRCULATION. 2016. 134
Nagako Sougawa, Shigeru Miyagawa, Satsuki Fukushima, Atsuhiro Saito, Shigeo Masuda, Akima Harada, Yukiko Imanishi, Ryoko Sato-Nishiuchi, Kiyotoshi Sekiguchi, Yoshiki Sawa. Modulation of Stem Cell Niche and Stem Cell Migration Promotes Functional Angiogenesis by Enhancing Stem Cell Homing in Ischemic Rat Myocardium: A Novel Concept of Cell-free Regeneration Therapy. CIRCULATION. 2015. 132
Emiko Ito, Shigeru Miyagawa, Atsuhiro Saito, Satsuki Fukushima, Shigeo Masuda, Takuji Kawamura, Yukiko Imanishi, Nagako Sougawa, Motoko Shiozaki, Hiroko Iseoka, et al. A Promising Highly Sensitive and Quantitative Assays of Tumorigenicity Essential for Facilitating Safety Studies of Human Induced Pluripotent Stem Cells -derived Cardiomyocytes for Future Therapeutic Application. CIRCULATION. 2014. 130
Masashi Kawamura, Shigeru Miyagawa, Satsuki Fukushima, Atsuhiro Saito, Yukiko Imanishi, Emiko Ito, Nagako Sougawa, Kenji Miki, Takuji Kawamura, Masaru Ishida, et al. Enhanced Therapeutic Effects of Human iPS Cell Derived Cardiomyocyte Transplantation by the Combination of Cell Sheets With the Pedicle Omental Flap Technique in a Porcine Ischemic Cardiomyopathy Model. CIRCULATION. 2013. 128. 22

ｍore...

Work history (8)：

2016/09/01 - 現在 Osaka University Graduate School of Medicine Assistant Professor
2016/04/01 - 2016/08/31 Osaka University Graduate School of Medicine Division of Medicine Specially Appointed Researcher
2010/10/01 - 2016/03/31 Osaka University Graduate School of Medicine Division of Medicine Specially Appointed Researcher
2010/08/01 - 2010/09/30 Osaka University Division of Surgical Medicine Specially Appointed Researcher
2008/10 - 2010/08 先端医療振興財団先端医療センター膵島肝臓再生研究グループ主任研究員

Show all

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page